| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 9, 2025 | May 13, 2025 | BRISTOL MYERS SQUIBB CO | President | Sell | 27.5 | -97 | -1.10% | ✗ | $3.7K |
| Mar 1, 2025 | Mar 4, 2025 | BRISTOL MYERS SQUIBB CO | President | Sell | 22.5 | -1,630 | -15.51% | ✗ | $97.2K |
| Feb 1, 2025 | Feb 4, 2025 | BRISTOL MYERS SQUIBB CO | President | Sell | 22.5 | -3,725 | -34.02% | ✗ | $219.6K |
| Oct 1, 2019 | Oct 1, 2019 | HALOZYME THERAPEUTICS, INC. | SVP, Chief Commerical Officer | Sell | 42.5 | -6,990 | -34.58% | ✗ | $108.1K |